Sold by: Next Move Strategy Consulting
Deployed on AWS
The CRISPR in Agriculture Market represents a transformative sector leveraging gene editing technology to boost crop yields, enhance resilience against climate challenges, and meet escalating global food needs. The market is poised for robust expansion to 3.26 billion USD by 2030, reflecting a compound annual growth rate of 19.4%.
Overview
The CRISPR in Agriculture Market overview highlights CRISPRs role in addressing pressing agricultural issues, including population growth projected to hit 10 billion by 2050, which demands a 60% surge in food production according to World Bank estimates. Innovations integrate artificial intelligence for precise breeding, enabling traits like drought tolerance and nutritional improvements in staples such as maize and soybean. Yet, ethical debates, delivery inefficiencies, and off target effects pose hurdles, tempered by opportunities in regulatory easing and public private collaborations.
Request for a FREE Sample PDF Report: https://www.nextmsc.com/crispr-in-agriculture-market-3430/request-sample
Market sizing underscores a swift trajectory, starting from 1.34 billion USD by end of 2025. Segmentation spans offerings like tools, instruments, software, services, licensing, and commercial products. CRISPR systems vary from Cas9 to Cas12 and Cas13, with editing modalities including knockouts, base edits, and insertions. Delivery methods encompass agrobacterium mediated approaches, biolistics, and viral vectors. Product types focus on seeds, biopesticides, and beyond, applied across row crops like corn and wheat, fruits, vegetables, and specialty varieties. Applications cover yield enhancement, stress tolerance, disease resistance, and livestock productivity, serving end users from research institutes to commercial farmers.
Inquire Before Buying: https://www.nextmsc.com/crispr-in-agriculture-market-3430/inquire-before-buying
Drivers fuel this momentum, with investments in gene editing startups soaring 206 percent in early 2024 to 161 million USD, spurred by climate imperatives. Precision agriculture and AI driven analytics, dubbed Breeding 4.0, leverage drones, satellites, and multi omics data for targeted edits. Global calls from Nobel laureates underscore gene editings potential for sustainable yields amid rising demands.
Restraints include ethical qualms over genetic modifications, technical gaps in cellular delivery, and risks from unintended edits, inviting rigorous oversight. Opportunities emerge in AI integration for phenotypic automation, reforms exempting certain edits from genetically modified organism labels in Asia Pacific and Europe, and initiatives for smallholder farmers, such as flood resistant rice in Southeast Asia.
Access Full Report: https://www.nextmsc.com/report/crispr-in-agriculture-market-3430
Challenges persist in scaling complex traits and navigating approval delays, particularly in cautious European markets bound by biodiversity rules. Key players like Corteva Agriscience, Bayer AG, Syngenta Group, BASF SE, and Pairwise Plants LLC dominate through partnerships and research hubs. Recent moves include Cortevas 25 million USD stake in Pairwise for resilient crops in September 2024, Bayers automated facility launch in July 2024, and Syngentas open access platform in June 2024 for academic breeders.
Competitive dynamics feature joint ventures, expansions, and R and D pushes, analyzed via SWOT, Porters Five Forces, and value chains. North America leads with policy support and investments, tackling anomalies like the 2.8 degrees Fahrenheit warmer June 2025 in the US. Europe advances moderately via sustainability aligned tools, while Asia Pacific surges fastest, backed by Chinas plans and Indias exemptions. Rest of World, including Africa, gains from training programs like the Nairobi CRISPR academy for 80 to 100 scientists over five years.
Insights reveal a sector ripe for innovation, with free report customizations up to 80 hours, covering 28 countries and 15 firms. This growth trajectory promises equitable food systems, blending technology with ecological stewardship for a resilient agricultural future.
Contact Us:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +18577585017
Website: https://www.nextmsc.com/
Details
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Vendor refund policy
All sales are final; no refunds or returns are accepted. Our reports include sensitive, researched data from various sources, including industry experts and paid services. We ensure confidentiality and offer customization at an additional cost. Please review our terms before purchase. For inquiries, contact customer service.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
NOTE: This deployment requires a specific SageMaker Inference AMI selection (al2-ami-sagemaker-inference-gpu-3-1). Please use the example notebook provided at https://github.com/NVIDIA/nim-deploy/blob/main/cloud-service-providers/aws/sagemaker/aws_marketplace_notebooks/nim-evo2-40b-v2-1-0_aws_marketplace.ipynb for deploying the endpoint.
Evo 2 is a biological foundation model that can interpret and generate DNA sequences across various biological scales: from individual molecules to entire genomes while retaining sensitivity to single-nucleotide changes, enabling zero-shot predictions and complex biological system designs.
The IGVF (Impact of Genomic Variation on Function) Consortium aims to understand how genomic variation affects genome function,
which in turn impacts phenotype. The NHGRI is funding this collaborative program that brings together teams of investigators who
will use state-of-the-art experimental and computational approaches to model, predict, characterize and map genome function, how
genome function shapes phenotype, and how these processes are affected by genomic variation. These joint efforts will produce a
catalog of the impact of genomic variants on genome function and phenotypes.
The Data Corpus consists of single-cell Genomics experiments (both single modal, and multimodal, typically snRNA-seq and snATAC-seq),
Characterization experiments using Massively Parallel Reporter Assays (MPRAs) and CRISPR-screens along with a variety of protein mutatation
assays, and Predictive Models.
There are a huge variety of files in IGVF that are stored in the AWS OpenData Set so we rec[...]
The global Altering Plant DNA Market size is predicted to reach USD 3.03 billion by 2030 with a CAGR of 15.4%. The sector is witnessing rapid growth, driven by the ability to develop crops with enhanced traits that meet both farmer and consumer needs.
The global Molecular Farming Market is projected to reach a value of USD 578.4 million by the end of 2025. It is expected to continue expanding, climbing to USD 1,180.2 million by 2030, reflecting a robust CAGR of 15.3% from 2025 to 2030. Also referred to as the biopharming market, this sector is witnessing strong growth fueled by an aging global population, a rise in infectious diseases, and increased agricultural output.